WEVA’s Pick of the Month

Every month, we select an open-access article as our WEVA’s Pick of the Month to encourage educational and professional development in the equine field. Please enjoy the article below for May



Use of serum amyloid A in equine medicine and surgery

Stine Jacobsen, Department of Veterinary Clinical Sciences, Section Medicine & Surgery, University of Copenhagen,
Agrovej 8, DK-2630 Taastrup, Denmark.
Email: stj@sund.ku.dk



Reason for our pick: Serum amyloid A (SAA) has become an important part of the management of equine patients in general practice and specialized hospital settings.  SAA may be used in all stages of patient management: (1) before diagnosis (to rule in/rule out inflammatory disease), (2) at the time of diagnosis (to assess the severity of inflammation and assist in prognosis), and (3) after diagnosis (to monitor changes in inflammatory activity in response to therapy, with relapse of disease, or with infectious/inflammatory complications).  This recent review addresses the use of acute phase serum amyloid A (SAA) protein to diagnose and monitor inflammation in horses.

WEVA 2024 May Pick of the Month



Trimethoprim-sulfonamide: a valid antimicrobial treatment in foals?

Kajsa Gustafsson, DVM, DECVS; Benjamin W. Sykes, BVMS, MBA, PhD, DACVIM; Denis Verwilghen, DVM, PhD, DES, DECVS; Katrien Palmers, DVM, DECEIM; Stacey Sullivan, BVSc, MVS, MPhil, DECEIM; Gaby van Galen, DVM, PhD, DECEIM, DECVECC


Reason for our pick: Considering the emergence of increased antimicrobial resistance, the use of protected antimicrobials commonly prescribed to foals should be avoided and alternative first-line therapy considered whenever appropriate. In this article, the characteristics of TMS and its suitability for the treatment of foals are reviewed and data regarding dosage and route of administration are reported. In this review the authors also identify common infections that are most likely responsive to TMS treatment in foals and where TMS might be considered a suitable first-line therapeutic option.

WEVA 2024 April Pick of the Month




Kallie J Hobbs, Kimberly A S Young, Sara Nannarone , Daniela Luethy , Charlotte Hopster-Iversen, Harold C McKenzie , Elsa K Ludwig. J Vet Intern Med. 2024 Jan-Feb;38(1):411-416.


Reason for our pick: All of us reach out for guidance and advice in situations where we encounter complications. Particularly complications that seem easily avoidable like losing a guidewire when placing an IV over-the-wire catheter. Although not all equine vets around the globe place O-T-W IV catheters regularly, chances aren’t too bad that – regardless of region – this complication is a realistic scenario. Knowing that our peers have experienced the same, it is beneficial to know how we should manage the situation and what the expected outcome and consequences are.